GT Biopharma Ownership | Who Owns GT Biopharma?


OverviewForecastFinancialsChart

GT Biopharma Ownership Summary


GT Biopharma is owned by 17.08% institutional investors, 3.46% insiders, and 79.46% retail investors. Geode capital management is the largest institutional shareholder, holding 5.34% of GTBP shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.27% of its assets in GT Biopharma shares.

GTBP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGT Biopharma17.08%3.46%79.46%
SectorHealthcare Stocks 35.42%11.83%52.76%
IndustryBiotech Stocks 35.46%11.78%52.76%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management294.46K5.34%$120.17K
Vanguard fiduciary trust225.94K4.10%$92.18K
Srs capital advisors93.63K1.70%$38.21K
Citadel advisors66.17K1.20%$27.00K
Seacrest wealth management50.00K0.91%$20.41K
Ubs group45.97K0.83%$18.76K
Two sigma securities31.80K0.58%$12.98K
Lpl financial30.38K0.55%$12.40K
Invst23.40K0.42%$9.55K
Advisor group21.00K0.38%$8.57K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Caitlin john16.50K0.00%$6.73K
Seacrest wealth management50.00K0.00%$20.41K
Private wealth management group20.00K0.00%$8.16K
Two sigma securities31.80K0.00%$12.98K
Coston, mcisaac & partners17.09K0.00%$6.00K
Am investment strategies15.00K0.00%$6.00K
Invst23.40K0.00%$9.55K
Srs capital advisors93.63K0.00%$38.21K
Lasalle st. investment advisors11.00K0.00%$4.49K
Stonex group14.76K0.00%$6.02K

Top Buyers

HolderShares% AssetsChange
Geode capital management294.46K-275.20K
Vanguard fiduciary trust225.94K-225.94K
Srs capital advisors93.63K0.00%93.63K
Ubs group45.97K-45.97K
Invst23.40K0.00%23.40K

Top Sellers

HolderShares% AssetsChange
Drw securities---142.38K
Scientech research---54.74K
Renaissance---26.30K
Jane street group---26.02K
Citadel advisors66.17K--14.60K

New Positions

HolderShares% AssetsChangeValue
Vanguard fiduciary trust225.94K-225.94K$92.18K
Srs capital advisors93.63K0.00%93.63K$38.21K
Invst23.40K0.00%23.40K$9.55K
Private wealth management group20.00K0.00%20.00K$8.16K
Virtu financial14.88K0.00%14.88K$6.00K

Sold Out

HolderChange
Sbi securities-1.00
Jpmorgan chase-1.00
Front row advisors-1.00
Blue bell private wealth management-10.00
Ghp investment advisors-33.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202620-47.37%941,79194.98%1711.37%10-60.00%1-87.50%
Dec 31, 20252938.10%284,740-23.91%73.96%20185.71%525.00%
Sep 30, 202520-374,21692.24%1319.59%7-36.36%433.33%
Jun 30, 2025215.00%189,92690.52%844.82%11120.00%3-40.00%
Mar 31, 20252011.11%99,688-91.98%40.10%5-28.57%5150.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr451.88K1.27%-
Fidelity Extended Market Index234.78K0.66%212.92K
Spartan Extended Market Index Pool E4.50K0.20%4.26K
Dimensional US Core Equity USD Acc2.20K0.10%-
Spartan Extended Market Index Pool F32.42K0.09%32.42K
Fidelity Series Total Market Index24.29K0.07%20.73K
BlackRock Extended Equity Market K1.16K0.05%-
Dimensional US Sustainability Core 1 ETF1.64K0.05%-
DFA US Sustainability Core 1799.000.04%-
Extended Equity Market Fund K1.12K0.03%-22.00

Recent Insider Transactions


DateNameRoleActivityValue
Apr 11, 2023Breen Michael Martin Executive Chairman/Interim CEOBuy$25.00K
Apr 06, 2023Ohri Manu CFO & SecretaryBuy$25.00K
Dec 22, 2020Wendel Bruce-Buy$12.19K
Nov 16, 2020Wendel Bruce-Buy$10.26K
Dec 22, 2020Wendel Bruce-Buy$3.85K

Insider Transactions Trends


DateBuySell
2023 Q22-
2023 Q1--
2022 Q3--
2022 Q2--
2022 Q1--

GTBP Ownership FAQ


Who Owns GT Biopharma?

GT Biopharma shareholders are primarily institutional investors at 17.08%, followed by 3.46% insiders and 79.46% retail investors. The average institutional ownership in GT Biopharma's industry, Biotech Stocks , is 35.46%, which GT Biopharma falls below.

Who owns the most shares of GT Biopharma?

GT Biopharma’s largest shareholders are Geode capital management (294.46K shares, 5.34%), Vanguard fiduciary trust (225.94K shares, 4.10%), and Srs capital advisors (93.63K shares, 1.70%). Together, they hold 11.14% of GT Biopharma’s total shares outstanding.

Does Blackrock own GT Biopharma?

BlackRock is not among the top 10 institutional shareholders of GT Biopharma.

Who is GT Biopharma’s biggest shareholder by percentage of total assets invested?

Caitlin john is GT Biopharma’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 16.5K GT Biopharma shares, valued at 6.73K$.

Who is the top mutual fund holder of GT Biopharma shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of GT Biopharma shares, with 1.27% of its total shares outstanding invested in 451.88K GT Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools